|
|
More information


This document contains certain forward-looking statements with respect to the financial condition, results of operations and
business of Philips and certain of the plans and objectives of Philips with respect to these items, in particular the Outlook
section of the chapter The Philips Group in this Annual Report. Examples of forward-looking statements include statements
made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. By their
nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances and
there are many factors that could cause actual results and developments to differ materially from those expressed or implied
by these forward-looking statements.
These factors include but are not limited to domestic and global economic and business conditions, the successful implementation
of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products,
changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs, raw materials
and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into
our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological
changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition.
As a result, Philips’ actual future results may differ materially from the plans, goals, and expectations set forth in such
forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking
statements, see also the chapter Risk management.
Statements regarding market share, including those regarding Philips’ competitive position, contained in this document are
based on outside sources such as specialized research institutes, industry and dealer panels in combination with management
estimates. Where full-year information regarding 2007 is not yet available to Philips, those statements may also be based
on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.
In presenting the Philips Group’s financial position, fair values are used for the measurement of various items in accordance
with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained
from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and
are only valid at the balance sheet date. When a readily determinable market value does not exist, fair values are estimated
using valuation models, which we believe are appropriate for their purpose. They require management to make significant assumptions
with respect to future developments which are inherently uncertain and may therefore deviate from actual developments. Critical
assumptions used are disclosed in the financial statements. In certain cases, independent valuations are obtained to support
management’s determination of fair values.
The financial information included in this document is based on US GAAP, unless otherwise indicated. The term EBIT has the
same meaning as Income from operations (IFO), and is used the evaluate the performance of the business.
In presenting and discussing the Philips Group's financial position, operating results and cash flows, management uses certain
non-US GAAP financial measures like: comparable growth; EBITA; NOC; net debt (cash); and cash flow before financing activities.
These non-US GAAP financial measures should not be viewed in isolation as alternatives to the equivalent US GAAP measures.
Further information on non-US GAAP information and a reconciliation of such measures to the most directly comparable US GAAP
measures can be found in the chapter Reconciliation of non-US GAAP information.
The chapters IFRS financial statements and Company financial statements contain the statutory financial statements. The introduction
to the chapter IFRS financial statements sets out which parts of this Annual Report form the management report within the
meaning of Section 2:391 of the Dutch Civil Code (and related Decrees).
On November 2, 2007, Philips announced that it has decided to proceed with the sale of its approximately 70% ownership interest
in MedQuist. Consequently prior periods’ consolidated financial statements have been restated to present the MedQuist business
as a discontinued operation.
As of January 2007, the following key portfolio changes have been applied to the Philips Group structure: Other Activities
was renamed Innovation & Emerging Businesses; Unallocated was renamed Group Management & Services; GSU activities and Miscellaneous
were transferred from Innovation & Emerging Businesses to Group Management & Services; Consumer Healthcare Solutions was moved
from DAP to Innovation & Emerging Businesses. Also as of January 2007, certain Corporate/Regional/Country overhead and Corporate
Intellectual Property costs were allocated to the operating divisions to further improve transparency of the total cost structure.
As a consequence of the aforementioned, prior-year financials have been restated.
|
|